Roche Answers Patient Group Questions about the UK Early Access to Medicines Scheme (EAMS) for Risdiplam

23 September 2020

This information is provided in response to a series of questions shared jointly with Roche in writing by UK patient organisations SMA UK, Muscular Dystrophy UK (MDUK), and TreatSMA.

Unless otherwise stated, this information applies to people living across the UK. 

Read the Q&As